Hostname: page-component-7b7567c8c-slfcl Total loading time: 0 Render date: 2026-11-19T08:17:09.850Z Has data issue: false hasContentIssue false

Possible Synergistic Effects of the New Thymoleptics in Connection with Poisoning

Published online by Cambridge University Press:  08 February 2018

E. Howarth*
Affiliation:
Cheadle Royal, Cheadle, Cheshire
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

During recent years, a good deal of attention has been drawn to the therapeutic and toxic effects of the new thymoleptics. Although most of these preparations have had a reasonable clinical trial before being released for general use, it is a fact that hitherto unsuspected toxic effects continue to come to light. Among the more recently discovered side-effects of Tofranil (imipramine) are the occurrence of jaundice and a tendency in certain patients to epileptic fits. Experimentally it has been shown that Tofranil increases the excitability of the brain of rabbits and may evoke convulsant spikes (1), and in a recent article by Leyberg and Denmark (2) it is recorded that in four cases of a relatively small series the dose of the drug had to be reduced on account of epileptic fits.

Information

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1961 
Submit a response

eLetters

No eLetters have been published for this article.